93 782
Pill imprint 93 782 has been identified as Tamoxifen citrate 20 mg.
Tamoxifen is used in the treatment of breast cancer; breast cancer, metastatic; precocious puberty; breast cancer, adjuvant; breast cancer, male (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy.
Tamoxifen 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Tamoxifen citrate Images
- Imprint:
-
93 782
- Strength:
- 20 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
hypromellose
lactose monohydrate
magnesium stearate
polyethylene glycol 400
povidone
corn starch
titanium dioxide
- Drug Class:
- Hormones/antineoplastics
Selective estrogen receptor modulators - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-0782
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4287 | Physicians Total Care Inc (repackager) |
| 54569-5857 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Tamoxifen Citrate resources
- Tamoxifen
- Tamoxifen (Wolters Kluwer)
- Tamoxifen Solution (Wolters Kluwer)
- tamoxifen (Cerner Multum)
- tamoxifen (Micromedex) - Includes Dosage Information
- Tamoxifen Citrate (AHFS DI)
- Tamoxifen (FDA)
- Tamoxifen Citrate (Wolters Kluwer)
Search Again
